Febuxostat

In the US, Febuxostat (febuxostat systemic) is a member of the drug class antihyperuricemic agents and is used to treat Gout.

US matches:

• Febuxostat

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

M04AA03

CAS registry number (Chemical Abstracts Service)

0144060-53-7

Chemical Formula

C16-H16-N2-O3-S

Molecular Weight

316

Therapeutic Category

Uricostatic agent

Chemical Names

2-(3-Cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid

2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid (WHO)

5-Thiazolecarboxylic acid, 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl- (USAN)

Foreign Names

• Febuxostatum (Latin)
• Febuxostat (German)
• Fébuxostat (French)
• Febuxostat (Spanish)

Generic Names

• Febuxostat (OS: USAN, JAN)
• TEI-6720 (IS)
• TMX-67 (IS)
• UNII-101V0R1N2E (IS)

Brand Names

• Adenuric
  Berlin-Chemie, Germany; Ipsen, France; Ipsen, Ireland



• Uloric
  Takeda, United States

International Drug Name Search

Glossary

IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.